{"transactions":[{"id":702623,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-07-28T20:54:24.000Z","date":"2026-07-24","kind":"grant","planned":false,"acquired":true,"shares":2538,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":17932,"source":{"system":"sec-edgar","filing":"0000313143-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000031314326000103/form4.xml","form_type":"4"}},{"id":766526,"issuer":{"id":4016,"kind":"organization","name":"Integer Holdings Corp","symbol":"ITGR"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T20:52:45.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":1967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\") as of May 20, 2026. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027."}],"balance_after":3322,"source":{"system":"sec-edgar","filing":"0001233311-26-000002","document":"wk-form4_1779483162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114483/000123331126000002/wk-form4_1779483162.xml","form_type":"4"}},{"id":1081677,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-25T20:23:00.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":2693,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":15394,"source":{"system":"sec-edgar","filing":"0001127602-25-019593","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760225019593/form4.xml","form_type":"4"}},{"id":1088166,"issuer":{"id":4016,"kind":"organization","name":"Integer Holdings Corp","symbol":"ITGR"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-14T23:08:10.000Z","date":"2025-07-10","kind":"grant","planned":false,"acquired":true,"shares":1355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units (\"RSUs\") as of July 10, 2025. RSUs convert into common stock on a one-for-one basis, subject to vesting in approximately equal installments on August 21, 2025,\nNovember 21, 2025, February 21, 2026 and May 19, 2026."}],"balance_after":1355,"source":{"system":"sec-edgar","filing":"0001114483-25-000128","document":"wk-form4_1752534484.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1114483/000111448325000128/wk-form4_1752534484.xml","form_type":"4"}},{"id":1448445,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-07-26T20:29:33.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2207,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":12701,"source":{"system":"sec-edgar","filing":"0001127602-24-021038","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760224021038/form4.xml","form_type":"4"}},{"id":1813448,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-08T20:29:12.000Z","date":"2023-08-04","kind":"grant","planned":false,"acquired":true,"shares":2226,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":10494,"source":{"system":"sec-edgar","filing":"0001127602-23-022200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760223022200/form4.xml","form_type":"4"}},{"id":2192467,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-08T21:27:15.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2730,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":8268,"source":{"system":"sec-edgar","filing":"0001127602-22-020697","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222020697/form4.xml","form_type":"4"}},{"id":2610957,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-08-09T23:18:18.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":3077,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":5538,"source":{"system":"sec-edgar","filing":"0001127602-21-023393","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221023393/form4.xml","form_type":"4"}},{"id":2829315,"issuer":{"id":1499,"kind":"organization","name":"iRhythm Holdings, Inc.","symbol":"IRTC"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-27T01:19:13.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":33247,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on February 1, 2022 and each one-year anniversary thereafter."}],"balance_after":33247,"source":{"system":"sec-edgar","filing":"0001388658-21-000041","document":"wf-form4_161438866349642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000138865821000041/wf-form4_161438866349642.xml","form_type":"4"}},{"id":2990934,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2020-11-05T22:53:04.000Z","date":"2020-11-03","kind":"tax_withholding","acquired":false,"shares":393,"price":103.13,"value":40530.09,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 220 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":190390,"source":{"system":"sec-edgar","filing":"0001127602-20-028274","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220028274/form4.xml","form_type":"4"}},{"id":3007057,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Performance Share Units","published_at":"2020-10-14T22:44:15.000Z","date":"2020-10-09","kind":"grant","acquired":true,"shares":21164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance share unit represents a contingent right to receive one share of Medtronic common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The number of shares to be issued  in connection with the performance share units (\"PSUs\") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,164 shares will be issued. The actual number of shares to be issued could range from a low of 4,233 at minimum performance to a high of 42,328 shares at maximum performance.  If minimum performance metrics are not met, such PSUs may vest at 0 shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests on August 3, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vests on August 3, 2023."}],"balance_after":21164,"derivative":{"underlying":"Performance Share Units","underlying_shares":21164},"source":{"system":"sec-edgar","filing":"0001127602-20-026952","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220026952/form4.xml","form_type":"4"}},{"id":3067133,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:52:53.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":49118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":49118,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":49118},"source":{"system":"sec-edgar","filing":"0001127602-20-022893","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220022893/form4.xml","form_type":"4"}},{"id":3067132,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:52:53.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":1575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1575,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":1575},"source":{"system":"sec-edgar","filing":"0001127602-20-022893","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220022893/form4.xml","form_type":"4"}},{"id":3067131,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-05T20:52:53.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":86901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":86901,"derivative":{"exercise_price":97.33,"exercise_date":"2021-08-03","expiration_date":"2030-08-03","underlying":"Ordinary Shares","underlying_shares":86901},"source":{"system":"sec-edgar","filing":"0001127602-20-022893","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220022893/form4.xml","form_type":"4"}},{"id":3067130,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2020-08-05T20:52:53.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":9453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date."}],"balance_after":190563,"source":{"system":"sec-edgar","filing":"0001127602-20-022893","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220022893/form4.xml","form_type":"4"}},{"id":3071197,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2020-08-03T21:33:41.000Z","date":"2020-07-31","kind":"tax_withholding","acquired":false,"shares":7922,"price":96.48,"value":764314.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 770 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":181110,"source":{"system":"sec-edgar","filing":"0001127602-20-022588","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760220022588/form4.xml","form_type":"4"}},{"id":3078427,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-22T21:17:57.000Z","date":"2020-07-21","kind":"grant","acquired":true,"shares":1983,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":2461,"source":{"system":"sec-edgar","filing":"0001127602-20-021977","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220021977/form4.xml","form_type":"4"}},{"id":3174816,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-17T20:30:05.000Z","date":"2020-04-16","kind":"grant","acquired":true,"shares":478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":478,"source":{"system":"sec-edgar","filing":"0001127602-20-014079","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220014079/form4.xml","form_type":"4"}},{"id":3367963,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-18T22:31:24.000Z","date":"2019-11-15","kind":"exercise","acquired":false,"shares":36874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":38.81,"expiration_date":"2022-07-30","underlying":"Ordinary Shares","underlying_shares":36874},"source":{"system":"sec-edgar","filing":"0001127602-19-033063","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219033063/form4.xml","form_type":"4"}},{"id":3367962,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-18T22:31:24.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":3797,"price":112.07,"value":425529.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $111.98 to $112.15, inclusive.  The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."}],"balance_after":188262,"source":{"system":"sec-edgar","filing":"0001127602-19-033063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219033063/form4.xml","form_type":"4"}},{"id":3367961,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-18T22:31:24.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":25710,"price":111.314,"value":2861882.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $110.96 to $111.88, inclusive.  The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."}],"balance_after":192059,"source":{"system":"sec-edgar","filing":"0001127602-19-033063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219033063/form4.xml","form_type":"4"}},{"id":3367960,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-18T22:31:24.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":7367,"price":110.585,"value":814679.695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $109.96 to $110.96, inclusive.  The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."}],"balance_after":217769,"source":{"system":"sec-edgar","filing":"0001127602-19-033063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219033063/form4.xml","form_type":"4"}},{"id":3367959,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-18T22:31:24.000Z","date":"2019-11-15","kind":"exercise","acquired":true,"shares":36874,"price":38.81,"value":1431079.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":225136,"source":{"system":"sec-edgar","filing":"0001127602-19-033063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219033063/form4.xml","form_type":"4"}},{"id":3369742,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-15T22:49:00.000Z","date":"2019-11-14","kind":"exercise","acquired":false,"shares":1202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":41.6,"expiration_date":"2022-10-29","underlying":"Ordinary Shares","underlying_shares":1202},"source":{"system":"sec-edgar","filing":"0001127602-19-032879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219032879/form4.xml","form_type":"4"}},{"id":3369741,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-15T22:49:00.000Z","date":"2019-11-14","kind":"exercise","acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":36874,"derivative":{"exercise_price":38.81,"expiration_date":"2022-07-30","underlying":"Ordinary Shares","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001127602-19-032879","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219032879/form4.xml","form_type":"4"}},{"id":3369740,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-15T22:49:00.000Z","date":"2019-11-14","kind":"sale","acquired":false,"shares":1202,"price":109.95,"value":132159.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":188262,"source":{"system":"sec-edgar","filing":"0001127602-19-032879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219032879/form4.xml","form_type":"4"}},{"id":3369739,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-15T22:49:00.000Z","date":"2019-11-14","kind":"exercise","acquired":true,"shares":1202,"price":41.6,"value":50003.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":189464,"source":{"system":"sec-edgar","filing":"0001127602-19-032879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219032879/form4.xml","form_type":"4"}},{"id":3369738,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-15T22:49:00.000Z","date":"2019-11-14","kind":"sale","acquired":false,"shares":900,"price":109.523,"value":98570.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $109.50 to $109.61, inclusive.  The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."}],"balance_after":188262,"source":{"system":"sec-edgar","filing":"0001127602-19-032879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219032879/form4.xml","form_type":"4"}},{"id":3369737,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-15T22:49:00.000Z","date":"2019-11-14","kind":"exercise","acquired":true,"shares":900,"price":38.81,"value":34929.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":189162,"source":{"system":"sec-edgar","filing":"0001127602-19-032879","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219032879/form4.xml","form_type":"4"}},{"id":3381876,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-04T23:26:05.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":1202,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":1202,"derivative":{"exercise_price":41.6,"expiration_date":"2022-10-29","underlying":"Ordinary Shares","underlying_shares":1202},"source":{"system":"sec-edgar","filing":"0001127602-19-031732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219031732/form4.xml","form_type":"4"}},{"id":3381875,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-04T23:26:05.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":37774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":37774,"derivative":{"exercise_price":38.81,"expiration_date":"2022-07-30","underlying":"Ordinary Shares","underlying_shares":37774},"source":{"system":"sec-edgar","filing":"0001127602-19-031732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219031732/form4.xml","form_type":"4"}},{"id":3381874,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-04T23:26:05.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":1202,"price":109.5,"value":131619.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":188262,"source":{"system":"sec-edgar","filing":"0001127602-19-031732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219031732/form4.xml","form_type":"4"}},{"id":3381873,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-04T23:26:05.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":1202,"price":41.6,"value":50003.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":189464,"source":{"system":"sec-edgar","filing":"0001127602-19-031732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219031732/form4.xml","form_type":"4"}},{"id":3381872,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-04T23:26:05.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":37774,"price":109.5,"value":4136253.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":188262,"source":{"system":"sec-edgar","filing":"0001127602-19-031732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219031732/form4.xml","form_type":"4"}},{"id":3381871,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-11-04T23:26:05.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":37774,"price":38.81,"value":1466008.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 243 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":226036,"source":{"system":"sec-edgar","filing":"0001127602-19-031732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219031732/form4.xml","form_type":"4"}},{"id":3448917,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-08-02T22:10:05.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":22128,"price":102.37,"value":2265243.36,"ownership":{"direct":true},"balance_after":188019,"source":{"system":"sec-edgar","filing":"0001127602-19-025929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219025929/form4.xml","form_type":"4"}},{"id":3448916,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-08-02T22:10:05.000Z","date":"2019-08-01","kind":"tax_withholding","acquired":false,"shares":7561,"price":102.37,"value":774019.57,"ownership":{"direct":true},"balance_after":210147,"source":{"system":"sec-edgar","filing":"0001127602-19-025929","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219025929/form4.xml","form_type":"4"}},{"id":3451942,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T21:45:34.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":1615,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1615,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":1615},"source":{"system":"sec-edgar","filing":"0001127602-19-025552","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219025552/form4.xml","form_type":"4"}},{"id":3451941,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-31T21:45:34.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":99045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":99045,"derivative":{"exercise_price":103.26,"exercise_date":"2020-07-29","expiration_date":"2029-07-29","underlying":"Ordinary Shares","underlying_shares":99045},"source":{"system":"sec-edgar","filing":"0001127602-19-025552","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219025552/form4.xml","form_type":"4"}},{"id":3451940,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2019-07-31T21:45:34.000Z","date":"2019-07-29","kind":"grant","acquired":true,"shares":14850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 2,157 shares due to exempt transactions such as dividend reinvestment."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of shares beneficially owned includes 521 ordinary shares that were inadvertently omitted from Mr. Coyle's previous filings. The previously omitted shares were issued upon the conversion of 545 ordinary shares of Covidien plc that were held by Mr. Coyle at the time of the acquisition by Medtronic plc in January 2015."}],"balance_after":217708,"source":{"system":"sec-edgar","filing":"0001127602-19-025552","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760219025552/form4.xml","form_type":"4"}},{"id":3834689,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"exercise","acquired":false,"shares":84060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option to purchase 84,060 New Medtronic ordinary shares for $34.88 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 84,060 Medtronic common stock shares for $34.88 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":34.88,"expiration_date":"2021-08-01","underlying":"Ordinary Shares","underlying_shares":84060},"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3834688,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"exercise","acquired":false,"shares":70984,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option to purchase 70,984 New Medtronic ordinary shares for $37.53 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 70,984 Medtronic common stock shares for $37.53 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":37.53,"expiration_date":"2020-08-02","underlying":"Ordinary Shares","underlying_shares":70984},"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3834687,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"exercise","acquired":false,"shares":23175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option to purchase 23,175 ordinary shares of New Medtronic for $43.15 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 23,175 Medtronic common stock shares for $43.15 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option."}],"balance_after":0,"derivative":{"exercise_price":43.15,"expiration_date":"2020-02-01","underlying":"Ordinary Shares","underlying_shares":23175},"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3834686,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"sale","acquired":false,"shares":145544,"price":95.498,"value":13899160.912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $95.365 to $95.665, inclusive.  The reporting person undertakes to provide to Medtronic plc , any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4."}],"balance_after":200180,"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3834685,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"exercise","acquired":true,"shares":84060,"price":34.88,"value":2932012.8,"ownership":{"direct":true},"balance_after":345724,"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3834684,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"exercise","acquired":true,"shares":70984,"price":37.53,"value":2664029.52,"ownership":{"direct":true},"balance_after":261664,"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3834683,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2018-08-23T20:36:38.000Z","date":"2018-08-22","kind":"exercise","acquired":true,"shares":23175,"price":43.15,"value":1000001.25,"ownership":{"direct":true},"balance_after":190680,"source":{"system":"sec-edgar","filing":"0001127602-18-026096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218026096/form4.xml","form_type":"4"}},{"id":3850664,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2018-08-07T20:29:15.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":7585,"price":90.48,"value":686290.8,"ownership":{"direct":true},"balance_after":167505,"source":{"system":"sec-edgar","filing":"0001127602-18-024843","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218024843/form4.xml","form_type":"4"}},{"id":3856679,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T19:44:04.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":1695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1695,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":1695},"source":{"system":"sec-edgar","filing":"0001127602-18-024238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218024238/form4.xml","form_type":"4"}},{"id":3856678,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-01T19:44:04.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":99414,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":99414,"derivative":{"exercise_price":89.08,"exercise_date":"2019-07-30","expiration_date":"2028-07-30","underlying":"Ordinary Shares","underlying_shares":99414},"source":{"system":"sec-edgar","filing":"0001127602-18-024238","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218024238/form4.xml","form_type":"4"}},{"id":3856677,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2018-08-01T19:44:04.000Z","date":"2018-07-30","kind":"grant","acquired":true,"shares":16465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share (\"EPS\") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance increased by 2155 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":175089,"source":{"system":"sec-edgar","filing":"0001127602-18-024238","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760218024238/form4.xml","form_type":"4"}},{"id":4245494,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T18:53:26.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":65103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":65103,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":65103},"source":{"system":"sec-edgar","filing":"0001127602-17-024704","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760217024704/form4.xml","form_type":"4"}},{"id":4245493,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-02T18:53:26.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant."}],"balance_after":1191,"derivative":{"exercise_price":83.97,"exercise_date":"2018-07-31","expiration_date":"2027-07-31","underlying":"Ordinary Shares","underlying_shares":1191},"source":{"system":"sec-edgar","filing":"0001127602-17-024704","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760217024704/form4.xml","form_type":"4"}},{"id":4245492,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2017-08-02T18:53:26.000Z","date":"2017-07-31","kind":"grant","acquired":true,"shares":16276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share growth during the 36 month period ending on the last day of the Company's fiscal year 2020 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee."}],"balance_after":156469,"source":{"system":"sec-edgar","filing":"0001127602-17-024704","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760217024704/form4.xml","form_type":"4"}},{"id":4247160,"issuer":{"id":2888,"kind":"organization","name":"Medtronic plc","symbol":"MDT"},"owners":[{"id":28424,"kind":"person","name":"COYLE MICHAEL J","position":1,"cik":"0001233311","reported_name":"COYLE MICHAEL J","relationship":{"officer":true,"officer_title":"EVP & Group Pres, Cardiac&Vasc"}}],"security":"Ordinary Shares","published_at":"2017-08-01T16:47:04.000Z","date":"2017-07-28","kind":"tax_withholding","acquired":false,"shares":7270,"price":84.29,"value":612788.3,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This balance increased by 1,994 shares due to exempt transactions such as dividend reinvestment."}],"balance_after":140193,"source":{"system":"sec-edgar","filing":"0001127602-17-024472","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233311/000112760217024472/form4.xml","form_type":"4"}}]}